首页> 外文期刊>Clinical ophthalmology >The effect of intravitreal bevacizumab on ocular blood flow in diabetic retinopathy and branch retinal vein occlusion as measured by laser speckle flowgraphy
【24h】

The effect of intravitreal bevacizumab on ocular blood flow in diabetic retinopathy and branch retinal vein occlusion as measured by laser speckle flowgraphy

机译:玻璃体腔注射贝伐单抗对糖尿病性视网膜病变和视网膜分支静脉阻塞的眼血流量的影响

获取原文
       

摘要

Background: This study evaluated the effect of intravitreal injection of bevacizumab (IVB) on macular edema associated with diabetic retinopathy (DME) or branch retinal vein occlusion (BRVOME) using laser speckle flowgraphy.Methods: A comparative interventional study of?25?eyes from?22?patients with macular edema (DME group:?12?eyes; BRVOME group:?13?eyes) who underwent IVB. Mean blur rate (MBR) was measured in the retinal artery, retinal vein, optic nerve head (ONH), and choroid before and after IVB. Results: In the BRVOME group, there was no significant change in MBR in the retinal artery, retinal vein or ONH, but choroidal MBR decreased significantly (P=0.04). In the DME group, the MBR in the retinal artery, retinal vein, ONH, and choroid decreased significantly (P=0.02, P=0.04, P<0.001, and P=0.04, respectively). In the DME group, pre-IVB MBR in the ONH was significantly correlated with post-IVB foveal thickness (R= -0.71, P=0.002). There was no such correlation in the BRVOME group in the ONH.Conclusion: IVB had a suppressive effect on circulation in eyes with DME but not in those with BRVOME. This suggests that this noninvasive and objective biomarker may be a useful part of pre-IVB evaluations and decision-making in DME.
机译:背景:这项研究使用激光散斑流式成像技术评估了玻璃体内注射贝伐单抗(IVB)对糖尿病性视网膜病变(DME)或视网膜分支静脉阻塞(BRVOME)相关的黄斑水肿的作用。接受IVB的22例黄斑水肿患者(DME组:12眼; BRVOME组:13眼)。在IVB之前和之后,测量视网膜动脉,视网膜静脉,视神经头(ONH)和脉络膜的平均模糊率(MBR)。结果:在BRVOME组中,视网膜动脉,视网膜静脉或ONH中的MBR没有明显变化,但脉络膜MBR显着降低(P = 0.04)。在DME组中,视网膜动脉,视网膜静脉,ONH和脉络膜中的MBR显着降低(分别为P = 0.02,P = 0.04,P <0.001和P = 0.04)。在DME组中,ONH中的IVB前MBR与IVB后中央凹厚度显着相关(R = -0.71,P = 0.002)。结论:IVB对DME眼的循环有抑制作用,而对BRVOME眼则无抑制作用。这表明,这种非侵入性和客观的生物标记物可能是DME中IVB前评估和决策的有用部分。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号